Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability

被引:0
|
作者
J J Luke
C I van de Wetering
C M Knudson
机构
[1] The University of Iowa Roy J. and Lucille P. Carver College of Medicine,Department of Pathology
[2] Molecular Biology Program,undefined
[3] The University of Iowa Roy J. and Lucille P. Carver College of Medicine,undefined
[4] Immunology Program,undefined
[5] The University of Iowa Roy J. and Lucille P. Carver College of Medicine,undefined
来源
关键词
apoptosis; oncogenesis; chromosomal instability;
D O I
暂无
中图分类号
学科分类号
摘要
Bax is a Bcl-2 family member that promotes apoptosis but has paradoxical effects on lymphoma development in p53-deficient mice. To better understand the mechanism of Bax-induced lymphoma development, the effect of Bax levels, p53 status and Bcl-2 coexpression on lymphoma development were determined. In addition, DNA content and cytogenetics were performed on young (premalignant) Lck-Bax mice as measures of genetic instability. Bax promoted lymphoma development in p53-deficient mice in a dose-dependent manner. Bax expression also led to lymphoma development in both p53 +/− and +/+ animals. Ploidy analysis in mice prior to the onset of overt thymic lymphomas demonstrated that Lck-Bax transgenic mice were more likely to be aneuploid and demonstrate increased chromosome instability. With tumor progression, aneuploidy increased and Bax expression was maintained. Importantly, coexpression of Bcl-2 delayed lymphoma development in Lck-Bax transgenic mice. These data support a model in which increased sensitivity to apoptosis leads directly to chromosome instability in developing T cells and may explain a number of paradoxical observations regarding Bcl-2 family members and the regulation of cancer.
引用
收藏
页码:740 / 748
页数:8
相关论文
共 50 条
  • [31] Bcl-2 transgenic mice are resistant to ischemia/reperfusion injury of the liver
    Rudiger, HA
    Sindrum, D
    Clavien, PA
    JOURNAL OF HEPATOLOGY, 2001, 34 : 9 - 10
  • [32] Nuclear partners of Bcl-2: Bax and PML
    Hoetelmans, RWM
    DNA AND CELL BIOLOGY, 2004, 23 (06) : 351 - 354
  • [33] The Bcl-2 associated X protein (Bax) and Bcl-2 homologous antagonist/killer (Bak) genes in human prostate cancer
    Yoshino, T
    Kikuno, N
    Honda, S
    Urakami, S
    Kishi, H
    Shigeno, K
    Shiina, H
    Igawa, M
    JOURNAL OF UROLOGY, 2003, 169 (04): : 89 - 89
  • [34] Bcl-2,Bax基因与肺癌
    高金莉
    国外医学(生理、病理科学与临床分册), 2001, (04) : 256 - 258
  • [35] Bcl-2、Bax基因与肺癌
    谢彤
    广西医学, 2001, (03) : 511 - 514
  • [36] Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2
    Tan, Chibing
    Dlugosz, Paulina J.
    Peng, Jun
    Zhang, Zhi
    Lapolla, Suzanne M.
    Plafker, Scott M.
    Andrews, David W.
    Lin, Jialing
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (21) : 14764 - 14775
  • [37] Bcl-2/Bax与脊髓损伤
    熊六波
    杨拯
    徐艳
    张晓
    中国康复理论与实践, 2009, (12) : 1147 - 1149
  • [38] Expression of bcl-2 and bax in glomerular disease
    Yoshimura, A
    Uda, S
    Inui, K
    Nemoto, T
    Sugenoya, Y
    Sharif, S
    Yokota, N
    Watanabe, S
    Ideura, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 : 55 - 57
  • [39] Cell death, Bcl-2, Bax, and the cerebellum
    Vogel M.W.
    The Cerebellum, 2002, 1 (4) : 277 - 287
  • [40] bcl-2、bax基因与胃癌
    姚国栋
    中国肿瘤, 2003, (11) : 36 - 38